Hicks Derek
SEC insider (Form 3/4/5 filer). CIK 0001901282. EVP, Chief Business Officer at Intellia Therapeutics, Inc. (NTLA). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 3, 2025. Located in CAMBRIDGE, MA.
Companies Hicks Derek has filed insider reports for
- Intellia Therapeutics, Inc. (NTLA): Officer, EVP, Chief Business Officer
Hicks Derek
CIK: 0001901282
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NTLA
Intellia Therapeutics, Inc.
Officer